189 related articles for article (PubMed ID: 7666230)
1. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
[TBL] [Abstract][Full Text] [Related]
2. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.
Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM
Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140
[TBL] [Abstract][Full Text] [Related]
3. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
[TBL] [Abstract][Full Text] [Related]
4. Etiology of cerebral vasospasm in primates.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Findlay JM; Saito K; Cook DA; Mielke BW; Kanamaru K
J Neurosurg; 1991 Sep; 75(3):415-24. PubMed ID: 1869943
[TBL] [Abstract][Full Text] [Related]
5. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage.
Takahashi M; Zhang ZD; Macdonald RL
J Neurosurg; 2011 Apr; 114(4):1104-9. PubMed ID: 20597600
[TBL] [Abstract][Full Text] [Related]
6. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
Pluta RM; Oldfield EH; Boock RJ
J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
[TBL] [Abstract][Full Text] [Related]
7. Surgical manipulation of primate cerebral arteries in established vasospasm.
Findlay JM; Macdonald RL; Weir BK; Grace MG
J Neurosurg; 1991 Sep; 75(3):425-32. PubMed ID: 1869944
[TBL] [Abstract][Full Text] [Related]
8. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
[TBL] [Abstract][Full Text] [Related]
9. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
Hara H; Nosko M; Weir B
J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
[TBL] [Abstract][Full Text] [Related]
11. Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707.
Macdonald RL; Johns L; Lin G; Marton LS; Hallak H; Marcoux F; Kowalczuk A
Neurol Med Chir (Tokyo); 1998; 38 Suppl():138-45. PubMed ID: 10234996
[TBL] [Abstract][Full Text] [Related]
12. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
Cirak B; Kiymaz N; Ari HH; Ugras S
Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelin in experimental cerebral vasospasm.
Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys.
Inoue T; Shimizu H; Kaminuma T; Tajima M; Watabe K; Yoshimoto T
Neurosurgery; 1996 Nov; 39(5):984-90. PubMed ID: 8905755
[TBL] [Abstract][Full Text] [Related]
16. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings.
Espinosa F; Weir B; Shnitka T; Overton T; Boisvert D
J Neurosurg; 1984 Jun; 60(6):1176-85. PubMed ID: 6726361
[TBL] [Abstract][Full Text] [Related]
17. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
[TBL] [Abstract][Full Text] [Related]
18. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
[TBL] [Abstract][Full Text] [Related]
20. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm.
Cosentino F; McMahon EG; Carter JS; Katusić ZS
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
